Trials / Completed
CompletedNCT06425757
Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Xie Kangjie · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Blood concentrations of Ciprofol were measured at different time points after single injection in patients with hypoproteinemia
Detailed description
This study was a single-center, interventional clinical study. Patients with different plasma albumin levels were selected before surgery and induced by a single injection of Ciprofol at a depth of 0.3 mg/kg. 2ml of venous blood was collected before and 0.5, 1, 2, 3, 5, 8, 15, 30min, 1h, 2h and 4h after administration. The pharmacokinetics of Ciprofol were studied by measuring the concentration of Ciprofol in blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ciprofol | Patients who intended to undergo elective surgery under general anesthesia were induced by a single intravenous injection of 0.3mg/kg and ciprofol, and the experimental drug was manually injected by CVC within 30s. 2ml of venous blood was collected before and after administration 0.5min, 1min, 2min, 3min, 5min, 8min, 15min 30min, 1h, 2h and 4h respectively. The concentration of cyclopofol in blood was measured |
Timeline
- Start date
- 2024-04-04
- Primary completion
- 2025-04-30
- Completion
- 2025-08-30
- First posted
- 2024-05-22
- Last updated
- 2025-10-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06425757. Inclusion in this directory is not an endorsement.